SI
ZGNX

Sofinnova Investments’s Zogenix, Inc. ZGNX Stock Holding History

Sofinnova Investments’s Portfolio ZGNX Stock Details ZGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-50,000
Closed -$2.39M – 89
2019
Q2 		$2.39M Buy
+50,000
New +$2.01M 0.22% 51

Other funds holding ZGNX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Sofinnova Investments's ZGNX Position: Q1 2021 in Review

Sofinnova Investments sold out of Zogenix, Inc. (ZGNX) in Q1 2021, closing a stake of 89,579 shares — an estimated $1.79M sold.

Sofinnova Investments first reported a position in ZGNX in Q1 2020 and held it in 2 quarters. The position peaked at $1.79M in Q4 2020. 157 funds tracked by Wall St. Rank hold ZGNX as of Q1 2021.

  • Sofinnova Investments reported no remaining Zogenix, Inc. position as of Q1 2021 after selling out during the quarter.
  • Sofinnova Investments sold 89,579 Zogenix, Inc. shares in Q1 2021, an estimated $1.79M.
  • Sofinnova Investments first reported a position in Zogenix, Inc. in Q1 2020 and held it in 2 quarters.
  • Sofinnova Investments's Zogenix, Inc. position peaked at $1.79M in Q4 2020.
  • 157 funds tracked by Wall St. Rank held Zogenix, Inc. as of Q1 2021.

Based on Sofinnova Investments's 13F filing for Q1 2021, filed 14 May 2021.